Glenmark Launches Generic Sodium Phosphates Injection in US
x
Glenmark Pharmaceuticals to launch generic sodium phosphates injection in the US market in April 2026. Equivalent to Hosira Inc''s drug.
New Delhi, Feb 27 (PTI) Glenmark Pharmaceuticals on Friday said its US-based unit is gearing up to introduce a generic sodium phosphates injection in the American market.
The Mumbai-based drug firm said its product is therapeutically equivalent to Hosira Inc's reference listed drug.
Glenmark will begin distribution of the injection in the US market in April 2026, it said in a regulatory filing.
According to IQVIA, sales data for the 12-month period ending December 2025, the Sodium Phosphates Injection USP single-dose vials saw annual sales of around USD 66.8 million.
Shares of the company were trading 0.82 per cent up at Rs 2,144.50 apiece on BSE. PTI MSS DR DR
DR
The Mumbai-based drug firm said its product is therapeutically equivalent to Hosira Inc's reference listed drug.
Glenmark will begin distribution of the injection in the US market in April 2026, it said in a regulatory filing.
According to IQVIA, sales data for the 12-month period ending December 2025, the Sodium Phosphates Injection USP single-dose vials saw annual sales of around USD 66.8 million.
Shares of the company were trading 0.82 per cent up at Rs 2,144.50 apiece on BSE. PTI MSS DR DR
DR
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Sunshine-Capital
- 0.24 ( -4.00)
- 92804738
- Ola-Electric-Mobilit
- 40.90 (+ 12.55)
- 60983668
- Alstone-Textiles
- 0.13 ( 0.00)
- 49024958
- Vodafone-Idea
- 9.25 (+ 1.31)
- 40027330
- AvanceTechnologies
- 1.26 (+ 9.57)
- 31438137
MORE NEWS
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback